FDA Inspection 1198326 — Miyoshi America, Inc

Miyoshi America, Inc — FEI 3009481791

The FDA completed an inspection of Miyoshi America, Inc on Jan 13, 2023 in Dayville, CT. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Jan 13, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Dayville, CT (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.